Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOBREADS: Neoadjuvant Breast Diet Study
NCT03822715Phase 1Terminated
- Start
- Mar 2019
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in breast cancer. Primary endpoint: Diet adherence at 6 months. Started Mar 2019; status: terminated.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03822715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822715.